Skip to main content
NCBI home page
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1969;40(5):639–719.

Codeine and its alternates for pain and cough relief*

4. Potential alternates for cough relief

Nathan B Eddy, Hans Friebel, Klaus-Jürgen Hahn, Hans Halbach
PMCID: PMC2554499  PMID: 4390406

Abstract

In this report—the fourth of a series on codeine and its alternates for pain and cough relief—an attempt is made to evaluate, on the basis of experimental and clinical data, and wherever possible in comparison with codeine, the effectiveness of a number of antitussive substances currently in clinical use. In the discussion of the undesired side-effects particular attention is paid to the risk of dependence and abuse.

Full text

PDF
639

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ABELMANN W. H., GAENSLER E. A., BADGER T. L. Clinical evaluation of toryn, a new synthetic cough depressant. Dis Chest. 1954 May;25(5):532–541. doi: 10.1378/chest.25.5.532. [DOI] [PubMed] [Google Scholar]
  2. ABRUZZI W. A. Clinical evaluation of levo propoxyphene, a new antitussive. J New Drugs. 1962 Sep-Oct;2:310–313. doi: 10.1177/009127006200200508. [DOI] [PubMed] [Google Scholar]
  3. ABSIRE-LAUPRETRE Y., DAILLY R. [Apropos of a new antitussive agent, noscapine camphosulfonate (Tulisan). Its utility in pediatric therapeutics]. Gaz Med Fr. 1962 Nov 10;69:3153–3155. [PubMed] [Google Scholar]
  4. ARAKI H., KITAMURA Y., KAGAMI T. [Clinical effects of oxolamine (Perebron)]. Minerva Med. 1961 Oct 31;52:3745–3747. [PubMed] [Google Scholar]
  5. ARCHIBALD D. W., SLIPP L. B., SHANE S. J. The evaluation of a cough suppressant: an exercise in clinical pharmacology. Can Med Assoc J. 1959 May 1;80(9):734–736. [PMC free article] [PubMed] [Google Scholar]
  6. AUROUSSEAU M., NAVARRO J. Etude comparative de la toxicité aiguë de quelques alcaloïdes dérivés de l'opium. Ann Pharm Fr. 1957 Nov;15(11):640–653. [PubMed] [Google Scholar]
  7. BALEA T., BURET J. SUR LES PROPRI'ET'ES PHARMACOLOGIQUES DE 2 SELS D'OXOLAMINE. Therapie. 1964 May-Jun;19:631–643. [PubMed] [Google Scholar]
  8. BALLI R. L'ASSOCIAZIONE OXOLAMINA CON TETRACICLINE NELLA TERAPIA DELLE AFFEZIONI BRONCHIALI DEI LARINGECTOMIZZATI. Minerva Otorinolaringol. 1963 Oct;13:310–313. [PubMed] [Google Scholar]
  9. BANYAI A. L. Cough and its management in elderly patients. Geriatrics. 1959 Oct;14:621–630. [PubMed] [Google Scholar]
  10. BANYAI A. L. Mechanism of cough and its control. GP. 1960 Mar;21:83–95. [PubMed] [Google Scholar]
  11. BARASZ Z., BONSTEIN H., AGUET F., FAVEZ G. [Comparative antitussive effects of noscapine hydrochloride and dihydrocodeine bitartrate. Experiments made without the awareness of the subject. (Doppel-Blindversuch, double blind test)]. Praxis. 1962 Mar 22;51:317–319. [PubMed] [Google Scholar]
  12. BARRANCO G., COTTONE D. L'impiego del carbetopentano in broncologia. Acta Anaesthesiol. 1958 May-Jun;9(3):171–180. [PubMed] [Google Scholar]
  13. BASABE H., GENTILE F. A., CROCIONI U. Experiencia clínica con un nuevo antitusígeno. Sem Med. 1957 May 30;110(23):766–passim. [PubMed] [Google Scholar]
  14. BASSI M., CITERNI S. [Clinical contribution to the therapeutic effectiveness of a new antitussive-antiphologistic preparation with an oxolamine citrate base, used alone and in combination with antibiotics]. Riforma Med. 1962 Jun 9;76:635–637. [PubMed] [Google Scholar]
  15. BECKLOFF G. L., HEWITT M. I. THE CLINICAL EVALUATION OF PIPAZETHATE ADMINISTERED RECTALLY IN 172 PEDIATRIC PATIENTS. Am J Med Sci. 1963 Sep;246:285–288. doi: 10.1097/00000441-196309000-00004. [DOI] [PubMed] [Google Scholar]
  16. BELLVILLE J. W., WALLENSTEIN S. L., WALD G. H., DOWLING M. D., Jr, HOUDE R. W. Effect of noscapine and codeine on the respiratory response to carbon dioxide. Anesthesiology. 1958 Jul-Aug;19(4):545–551. doi: 10.1097/00000542-195807000-00012. [DOI] [PubMed] [Google Scholar]
  17. BENSON W. M., STEFKO P. L., RANDALL L. O. Comparative pharmacology of levorphan, racemorphan and dextrorphan and related methyl ethers. J Pharmacol Exp Ther. 1953 Oct;109(2):189–200. [PubMed] [Google Scholar]
  18. BERGER F. Zur Therapie des Hustens mit "Ticarda". Munch Med Wochenschr. 1951 Jan 12;93(2):83–86. [PubMed] [Google Scholar]
  19. BICKERMAN H. A., BARACH A. L. The experimental production of cough in human subjects induced by citric acid aerosols; preliminary studies on the evaluation of antitussive agents. Am J Med Sci. 1954 Aug;228(2):156–163. doi: 10.1097/00000441-195408000-00005. [DOI] [PubMed] [Google Scholar]
  20. BICKERMAN H. A. Clinical pharmacology of antitussive agents. Clin Pharmacol Ther. 1962 May-Jun;3:353–368. doi: 10.1002/cpt196233353. [DOI] [PubMed] [Google Scholar]
  21. BICKERMAN H. A., GERMAN E., COHEN B. M., ITKIN S. E. The cough response of healthy human subjects stimulated by citric acid aerosol. II. Evaluation of antitussive agents. Am J Med Sci. 1957 Aug;234(2):191–206. doi: 10.1097/00000441-195708000-00010. [DOI] [PubMed] [Google Scholar]
  22. BICKERMAN H. A., ITKIN S. E. Further studies on the evaluation of antitussive agents employing experimentally induced cough in human subjects. Clin Pharmacol Ther. 1960 Mar-Apr;1:180–191. doi: 10.1002/cpt196012180. [DOI] [PubMed] [Google Scholar]
  23. BLANKART R. KLINISCHE ERFAHRUNGEN MIT EINEM NARCOTINHALTIGEN HUSTENMITTEL. Ther Umsch. 1963 Sep;20:403–406. [PubMed] [Google Scholar]
  24. BOISSIER J. R., PAGNY J. [Antitussive action of a non-barbituric hypnotic, metolquizolone]. Med Exp Int J Exp Med. 1959;1:368–372. [PubMed] [Google Scholar]
  25. BOISSIER J. R., PAGNY J. [Antitussive action of some phenothiazines]. Therapie. 1960;15:97–102. [PubMed] [Google Scholar]
  26. BOISSIER J. R., PAGNY J. [Comparative experimental action of 3 antitussive agents derived from phenylaminopropane]. Therapie. 1960;15:93–96. [PubMed] [Google Scholar]
  27. BONER H. [Ability of antitussives to modify the sneezing reflex]. Helv Physiol Pharmacol Acta. 1962;20:316–325. [PubMed] [Google Scholar]
  28. BORGO M. [On the use of oxolamine alone or in combination with tetracycline in the therapy of inflammations of the respiratory tract]. Policlinico Prat. 1962 Oct 29;69:1572–1575. [PubMed] [Google Scholar]
  29. BOYD C. E., BOYD E. M. Levo propoxyphene and respiratory tract fluid. J New Drugs. 1962 Jan-Feb;2:23–25. [PubMed] [Google Scholar]
  30. BOYD E. M., DAICAR A. O., MIDDLETON R. J. Apomorphine, muclene, pholcodine and vomiting upon respiratory tract fluid output. Ther Umsch. 1956 Dec;13(12):254–257. [PubMed] [Google Scholar]
  31. BOYD E. M., HICKS R. N., TRAINOR A. V. Racemorphan, dextromethorphan and respiratory tract fluid. Arch Int Pharmacodyn Ther. 1956 Jan 1;104(3-4):424–434. [PubMed] [Google Scholar]
  32. BRAENDEN O. J., EDDY N. B., HALBACH H. Synthetic substances with morphine-like effect; relationship between chemical structure and analgesic action. Bull World Health Organ. 1955;13(6):937–998. [PMC free article] [PubMed] [Google Scholar]
  33. BRENNER-GOEDDERZ L. [Peracon in practice. Experiences with a new kind of antitussive agent]. Med Klin. 1959 Oct 30;54:2004–2006. [PubMed] [Google Scholar]
  34. BUCHEGGER G., FRISCH P. Zur Vervollständigung der absoluten Bettruhe bei der Behandlung der cavernösen Lungentuberkulose. Med Klin. 1954 Nov 12;49(46):1846–1849. [PubMed] [Google Scholar]
  35. BUCHER K., JACOT C. Zum Mechanismus des Hustens. Helv Physiol Pharmacol Acta. 1951 Dec;9(4):454–462. [PubMed] [Google Scholar]
  36. BUCHER K. Tessalon, ein hustenstillendes Mittel von neuartigem Wirkungsmechanismus. Schweiz Med Wochenschr. 1956 Jan 28;86(4):94–96. [PubMed] [Google Scholar]
  37. BUCHHEIM K. L., ANGERMANN B. "Ticarda" ein neues hustensstillendes Mittel. Dtsch Med Wochenschr. 1951 Oct 12;76(41):1278–1279. doi: 10.1055/s-0028-1117461. [DOI] [PubMed] [Google Scholar]
  38. BUHLER F. Ticarda-Süchtigkeit. Medizinische. 1954 Sep 11;37:1245–1246. [PubMed] [Google Scholar]
  39. BURKHARDT H., ORZECHOWSKI G. Ticardasucht. Arch Toxikol. 1954;15(2):135–140. [PubMed] [Google Scholar]
  40. CAHEN R. L., GROSKINSKY E., PARISEK P. Anticonvulsant effect of morpholinethylmorphine. Proc Soc Exp Biol Med. 1956 Jun;92(2):305–308. doi: 10.3181/00379727-92-22459. [DOI] [PubMed] [Google Scholar]
  41. CAHEN R., AUBRON S. [Histaminogenic effect of morpholinethylmorphine]. C R Seances Soc Biol Fil. 1960 Dec 19;251:3111–3113. [PubMed] [Google Scholar]
  42. CAHEN R., BOUCHERLE A. ETUDE PHARMACOLOGIQUE DE LA NICOTINYLDIHYDROCOD'EINE. C R Seances Soc Biol Fil. 1964;158:1021–1024. [PubMed] [Google Scholar]
  43. CAHEN R., BOUCHERLE A., NADAUD J., CHARIOT J., TAURAND S., CLEREMBEAUX N. [Pharmacological study of the nicotinic ester of codeine]. Arch Int Pharmacodyn Ther. 1963;143:466–478. [PubMed] [Google Scholar]
  44. CAHEN R., BOUCHERLE A. [Comparative study of some nicotinic esters and some salts of codeine and morpholinoethylmorphine]. C R Seances Soc Biol Fil. 1961;155:1034–1035. [PubMed] [Google Scholar]
  45. CAHEN R., BOUCHERLE A. [Pharmacological properties of the nicotinic ester of codeine and of morpholinylethylmorphine]. J Physiol (Paris) 1961 Mar-Apr;53:286–287. [PubMed] [Google Scholar]
  46. CAHEN R. ["Anxioleptic" effect of morpholinethylmorphine]. Therapie. 1962 Mar-Apr;17:311–318. [PubMed] [Google Scholar]
  47. CAHEN R. [Comparative action of morphine and its morpholinylethylic ether]. C R Hebd Seances Acad Sci. 1959 Oct 5;249:1288–1290. [PubMed] [Google Scholar]
  48. CAHEN R. [Mechanism of the hypotensive effect of morpholinoethylmorphine. Appearance of tachyphylaxis]. C R Hebd Seances Acad Sci. 1960 May 23;250:3530–3532. [PubMed] [Google Scholar]
  49. CANEPA F., DE GAETANI G., MARCHESE S., TEDOLDI A. [Clinico-experimental data on the therapeutic use of oxolamine]. Arch Maragliano Patol Clin. 1962 Oct;18:641–651. [PubMed] [Google Scholar]
  50. CAPPELLO G., DI PASQUALE S. Traitement de la toux avec le bromhydrate de dextrométhorphane (Romilar) en tuberculose. Schweiz Z Tuberk. 1955;12(1):80–88. [PubMed] [Google Scholar]
  51. CARTER C. H. A clinical evaluation of the effectiveness of Novrad and acetylsalicylic acid in children with cough. Am J Med Sci. 1963 Jun;245:713–717. [PubMed] [Google Scholar]
  52. CARTER C. H., MALEY M. C. The clinical value of toclase in suppressing the cough reflex. Am J Med Sci. 1957 Jan;233(1):77–79. doi: 10.1097/00000441-195701000-00013. [DOI] [PubMed] [Google Scholar]
  53. CASS L. J., FREDERIK W. S., ANDOSCA J. B. Quantitative comparison of dextromethorphan hydrobromide and codeine. Am J Med Sci. 1954 Mar;227(3):291–296. [PubMed] [Google Scholar]
  54. CASS L. J., FREDERIK W. S. Evaluation of a new antitussive agent. N Engl J Med. 1953 Jul 23;249(4):132–136. doi: 10.1056/NEJM195307232490402. [DOI] [PubMed] [Google Scholar]
  55. CASS L. J., FREDERIK W. S. Quantitative comparison of cough-suppressing effects of romilar and other antitussives. J Lab Clin Med. 1956 Dec;48(6):879–885. [PubMed] [Google Scholar]
  56. CASS L. J., FREDERIK W. S. THE CLINICAL EVALUATION OF SILOMAT AS AN ANTITUSSIVE. Curr Ther Res Clin Exp. 1964 Jan;6:14–20. [PubMed] [Google Scholar]
  57. CASS L. J., LAING J. T., FREDERIK W. S. Physical dependence potentiality of analgesics. Curr Ther Res Clin Exp. 1961 Jul;3:289–299. [PubMed] [Google Scholar]
  58. CATTANEO A. D. [Experiences with tessalon in peroral endoscopy]. Minerva Anestesiol. 1959 Sep;25:373–375. [PubMed] [Google Scholar]
  59. CELA G., SOCCIO N. [Results obtained with a recent sedative for cough: Silomat]. Gazz Med Ital. 1963 Feb;122:61–63. [PubMed] [Google Scholar]
  60. CHABRIER P., GIUDICELLI R., THUILLIER J. Etude chimique, pharmacologique et clinique d'un nouveau sédatif de la toux: la morpholyléthylmorphine (M.E.M.). Ann Pharm Fr. 1950 Apr;8(4):261–273. [PubMed] [Google Scholar]
  61. CHAKRAVARTY N. K., MATALLANA A., JENSEN R., BORISON H. L. Central effects of antitussive drugs on cough and respiration. J Pharmacol Exp Ther. 1956 Jun;117(2):127–135. [PubMed] [Google Scholar]
  62. CHAPPEL C. I., STEGEN M. G., GRANT G. A. Pharmacological studies on new synthetic antitussive agents. Can J Biochem Physiol. 1958 May;36(5):475–481. [PubMed] [Google Scholar]
  63. CHAPTAL J., JEAN R., JARRIGE J. C. ESSAIS CLINIQUES D'UN NOUVEAU PRODUIT ANTI-INFLAMMATOIRE ET ANTI-TUSSIQUE DES VOIES RESPIRATOIRES CHEZ L'ENFANT. Ann Pediatr (Paris) 1964 Jan-Jul;11:384–386. [PubMed] [Google Scholar]
  64. CHEN J. Y., BILLER H. F., MONTGOMERY E. G., Jr Pharmacologic studies of a new antitussive, alpha (dimethylaminoethyl)-ortho-chlorobenzhydrol hydrochloride (SL-501, Bayer B-186). J Pharmacol Exp Ther. 1960 Apr;128:384–391. [PubMed] [Google Scholar]
  65. CHERNISH S. M., LEWIS G., KRAFT B., HOWELL H. CLINICAL EVALUATION OF A NEW ANTITUSSIVE PREPARATION. Ann Allergy. 1963 Dec;21:677–682. [PubMed] [Google Scholar]
  66. CHRISTOFFEL P., KOLBERG H. Die antitussive Wirkung eines Aminonitrils. Med Klin. 1958 Aug 29;53(35):1507–1509. [PubMed] [Google Scholar]
  67. CIESLAK G. Uber suchtmachende Hustenmittel. Nervenarzt. 1955 Jan 20;26(1):30–32. [PubMed] [Google Scholar]
  68. CORBELLA E. G. [Preliminary clinical experience with oxolamine citrate, new synthetic cough remedy]. Minerva Med. 1960 Dec 1;51:4077–4086. [PubMed] [Google Scholar]
  69. CUOCOLO R., MESSINA N., CARBONE M. [Results of clinical trials of a new sedative for cough (1-p-chloro-phenyl-2, 3-dimethyl-4-dimethylamino-2-butanol HC1. Possibilities of its use in surgery]. Rass Int Clin Ter. 1962 Jun 15;42:587–594. [PubMed] [Google Scholar]
  70. CZERMAK L. [Silomat in the therapy of pertussis]. Dtsch Med J. 1963 Jan 5;14:21–24. [PubMed] [Google Scholar]
  71. Calesnick B., Christensen J. A. Latency of cough response as a measure of antitussive agents. Clin Pharmacol Ther. 1967 May-Jun;8(3):374–380. doi: 10.1002/cpt196783374. [DOI] [PubMed] [Google Scholar]
  72. DARKE C. S., SNOWDEN B. A., VEREL D., DALY J. J., LAYLAND W. R. Action of tessalon on the dyspnoea of patients with chronic lung disease. Br Med J. 1959 Mar 7;1(5122):622–624. doi: 10.1136/bmj.1.5122.622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. DAVID A., LEITH-ROSS F., VALLANCE D. K. Antitussive and other pharmacological properties of the diethylaminoethoxyethyl ester of alpha alpha-diethylphenylacetic acid, (oxeladin). J Pharm Pharmacol. 1957 Jul;9(7):446–458. doi: 10.1111/j.2042-7158.1957.tb12297.x. [DOI] [PubMed] [Google Scholar]
  74. DAVID J. C. Cough and anti-tussive agents. J Christ Med Assoc India. 1961 May;36:183–186. [PubMed] [Google Scholar]
  75. DE GREGORIO M. [Anti-tussive activity in man and pharmaco-therapeutic characteristics of oxolamine (Perebron)]. Minerva Med. 1960 Dec 1;51:4086–4090. [PubMed] [Google Scholar]
  76. DEGKWITZ R. DEXTROMETHORPHAN (ROMILAR) ALS RAUSCHMITTEL. Nervenarzt. 1964 Sep;35:412–414. [PubMed] [Google Scholar]
  77. DEIDDA C. [Clinical experience with Perebron, a synthetic antitussive-anti-inflammatory agent]. Minerva Med. 1960 Dec 1;51:4059–4064. [PubMed] [Google Scholar]
  78. DIETEL K., KOEDITZ H. [On the use of Selvigon in pediatrics]. Ther Ggw. 1962 Mar;101:133–134. [PubMed] [Google Scholar]
  79. DOMENJOZ R. Zur Auswertung hustenstillender Arzneimittel. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1952;215(1-2):19–24. [PubMed] [Google Scholar]
  80. DREYER H. H. [New possibilities in appropriate cough therapy]. Ther Ggw. 1961 Dec;100:608–610. [PubMed] [Google Scholar]
  81. Dahlgren S., Dalhamn T. The effect of oxolamine citrate on experimentally produced inflammation in the respiratory organs. Acta Pharmacol Toxicol (Copenh) 1966;24(2):286–296. doi: 10.1111/j.1600-0773.1966.tb00391.x. [DOI] [PubMed] [Google Scholar]
  82. Doyle F. P., Mehta M. D. Antitussives. Adv Drug Res. 1964;1:107–159. [PubMed] [Google Scholar]
  83. EBERMANN H. Uber einen Fall von Ticarda-Sucht. Munch Med Wochenschr. 1954 Aug 13;96(33):922–923. [PubMed] [Google Scholar]
  84. EDDY N. B., HALBACH H., BRAENDEN O. J. Synthetic substances with morphine-like effect: clinical experience; potency, side-effects, addiction liability. Bull World Health Organ. 1957;17(4-5):569–863. [PMC free article] [PubMed] [Google Scholar]
  85. EDDY N. B., HALBACH H., BRAENDEN O. J. Synthetic substances with morphine-like effect; relationship between analgesic action and addiction liability, with a discussion of the chemical structure of addiction-producing substances. Bull World Health Organ. 1956;14(3):353–402. [PMC free article] [PubMed] [Google Scholar]
  86. EDDY N. B., TOUCHBERRY C. F., LIEBERMAN J. E. Synthetic analgesics; methadone isomers and derivatives. J Pharmacol Exp Ther. 1950 Feb;98(2):121–137. [PubMed] [Google Scholar]
  87. EIDMANN W. Klinische Erfahrungen mit einer neuen chemischen Substanz auf dem Gebiet der Hustenstillung (alpha-[Isopropyl]-alpha-[beta-dimethylaminopropyl]-phenylacetonitrilcitrat). Munch Med Wochenschr. 1959 Apr 10;101(15):676–677. [PubMed] [Google Scholar]
  88. ELEFANTE E. [Clinical contribution to the study of the therapeutic activity of oxolamine citrate]. Gazz Med Ital. 1962 Jun;121:160–163. [PubMed] [Google Scholar]
  89. ELLIS G. P., GOLBERG L., KING J., SHEARD P. THE SYNTHESIS AND ANTITUSSIVE PROPERTIES OF SOME CYCLOPENTANE DERIVATIVES. J Med Chem. 1963 Mar;6:111–117. doi: 10.1021/jm00338a006. [DOI] [PubMed] [Google Scholar]
  90. ENGELHORN R. [Pharmacological research on a new antitussive agent, 1-(p-chlorophenyl)-2,3-dimethyl-4-dimethyl-amino-2-butanol HC1]. Arzneimittelforschung. 1960 Oct;10:785–794. [PubMed] [Google Scholar]
  91. Ewart R. B., Priest R. G. Methaqualone addiction and delirium tremens. Br Med J. 1967 Jul 8;3(5557):92–93. doi: 10.1136/bmj.3.5557.92. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. FEINSILVER O. The use of tessalon in the preparation of the patient for bronchoscopy and bronchography. Curr Ther Res Clin Exp. 1961 Nov;3:451–456. [PubMed] [Google Scholar]
  93. FISCHMAN M. E. Pipazethate suppositories for the suppression of cough in pediatric practice. A report on 61 cases. Arch Pediatr. 1962 Sep;79:332–334. [PubMed] [Google Scholar]
  94. FLECKER A. [Experimental and clinical studies with a new antitussive agent]. Wien Med Wochenschr. 1961 Feb 11;111:114–118. [PubMed] [Google Scholar]
  95. FOUARGE M. [1-p-Chlorophenyl-2,3-dimethyl-4-dimethyl-amino-2-butanol HCl, a new synthetic cough sedative. Its application in direct laryngoscopy and bronchoscopy]. Scalpel (Brux) 1963 Jun 15;116:511–520. [PubMed] [Google Scholar]
  96. FRANCESCHETTI L. Sull'uso per via aerosolica di un nuovo sedativo della tosse. Gazz Med Ital. 1958 May;117(5):213–215. [PubMed] [Google Scholar]
  97. FRIEBEL H., KUHN H. F. [On cough and respiration depressive effect]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1962;243:162–173. [PubMed] [Google Scholar]
  98. FRIEBEL H., REICHLE C., VON GRAEVENITZ A. Zur Hemmung des Hustenreflexes durch zentral angreifende Arzneimittel. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1955;224(4):384–400. [PubMed] [Google Scholar]
  99. FRIEBEL H., REICHLE C. Versuchstierart und Testergebnis bei Prüfung schmerz- und hustenstillender Arzneimittel. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1956;229(4):400–407. [PubMed] [Google Scholar]
  100. FROEHLICH W., HERTZOG J. Becantex in der Behandlung des Hustens bei Tbc-Patienten. Praxis. 1953 Nov 12;42(46):974–976. [PubMed] [Google Scholar]
  101. GEFTER W. I. A new non-narcotic antitussive agent. Pa Med J. 1961 Sep;64:1137–1139. [PubMed] [Google Scholar]
  102. GERLAND W. [Experience with a new cough depressant active substance for children]. Med Welt. 1960 Dec 3;49:2611–2613. [PubMed] [Google Scholar]
  103. GHISLERI G. [On the use of a new antitussive drug]. Minerva Med. 1960 Sep 15;51:3102–3103. [PubMed] [Google Scholar]
  104. GIUDICELLI R., CHABRIER P., KRISTENSSON K. Etude chimique et pharmacologique de quelques nouveaux dérivés de la morphine. Therapie. 1951;6(3):146–154. [PubMed] [Google Scholar]
  105. GIUDICI G., LEGNANI F. [On the anti-inflammatory action of oxolamine citrate]. Minerva Med. 1961 Oct 31;52:3752–3755. [PubMed] [Google Scholar]
  106. GIULIANO V., ROSSA G. Esperienze cliniche sull'impiego di un nuovo preparato antitosse nella tubercolosi polmonare. Minerva Med. 1955 Nov 24;46(94):1502–1504. [PubMed] [Google Scholar]
  107. GLICK J. Codeine vs. caramiphen in cough control. Del Med J. 1963 Jul;35:180–180. [PubMed] [Google Scholar]
  108. GOSSWALD R. 1-Phenyl-1-(o-chlorphenyl)-3-dimethylamino-propanol-(1), ein neuer hustenhemmender Stoff. Arzneimittelforschung. 1958 Aug;8(8):550–553. [PubMed] [Google Scholar]
  109. GRAFE G. Hustenstillung zur Unterstützung diagnostischer und therapeutischer Eingriffe bei Lungenkrankheiten. Medizinische. 1958 Oct 25;43:1741–1742. [PubMed] [Google Scholar]
  110. GRAHAM J. D. Cough suppressants. Practitioner. 1959 Sep;183:344–350. [PubMed] [Google Scholar]
  111. GRAHAM J. D. Evaluation of isoaminile citrate as an antitussive. J New Drugs. 1962 Jan-Feb;2:43–49. [PubMed] [Google Scholar]
  112. GRANIER-DOYEUX M., HORANDE M., KUCHARSKI W. [Method for the quantitative evaluation of antitussive agents]. Arch Int Pharmacodyn Ther. 1959 Sep 1;121:287–296. [PubMed] [Google Scholar]
  113. GRAVENSTEIN J. S., BEECHER H. K. Ein Beitrag zur Auswertung hustendämpfender Substanzen am Menschen. Arzneimittelforschung. 1955 Jul;5(7):364–367. [PubMed] [Google Scholar]
  114. GRAVENSTEIN J. S., DEVLOO R. A., BEECHER H. K. Effect of antitussive agents on experimental and pathological cough in man. J Appl Physiol. 1954 Sep;7(2):119–139. doi: 10.1152/jappl.1954.7.2.119. [DOI] [PubMed] [Google Scholar]
  115. GREEN A. F., WARD N. B. The action of analgesics and nalorphine on the cough reflex. Br J Pharmacol Chemother. 1955 Dec;10(4):418–423. doi: 10.1111/j.1476-5381.1955.tb00096.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  116. GREGOIRE F., THIBAUDEAU Y., COMEAU M. The treatment of cough by a non-narcotic antitussive. Can Med Assoc J. 1958 Aug 1;79(3):180–184. [PMC free article] [PubMed] [Google Scholar]
  117. GREIF S. [Clinical evaluation of a new antitussive agent]. Wien Med Wochenschr. 1960 Nov 19;110:943–945. [PubMed] [Google Scholar]
  118. GROSZMAN M., BERKER I. O., CASIMIR F. An evaluation of an antitussive agent preparation Ciba 10611 (Melipan). Appl Ther. 1961 Feb;3:95–100. [PubMed] [Google Scholar]
  119. GRUBER C. M., Jr, CARTER C. H. A measure of the effectiveness of propoxyphene antitussives in children. Am J Med Sci. 1961 Oct;242:443–447. doi: 10.1097/00000441-196110000-00007. [DOI] [PubMed] [Google Scholar]
  120. GRUHZIT C. C. Chemoreflex activity of dextromethorphan (romilar), dextrorphan, codeine and morphine in the cat and the dog. J Pharmacol Exp Ther. 1957 Aug;120(4):399–407. [PubMed] [Google Scholar]
  121. GYANG E. A., KOSTERLITZ H. W., LEES G. M. THE INHIBITION OF AUTONOMIC NEURO-EFFECTOR TRANSMISSION BY MORPHINE-LIKE DRUGS AND ITS USE AS A SCREENING TEST FOR NARCOTIC ANALGESIC DRUGS . Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1964 May 25;248:231–246. doi: 10.1007/BF00348594. [DOI] [PubMed] [Google Scholar]
  122. HAAS H. Vergleichende Untersuchungen über Analgetica. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1955;225(5):442–452. [PubMed] [Google Scholar]
  123. HAHN L. A., WILBRAND H. The cough alleviating effect of beta-(diphenylmethoxy)-ethyl-trimethylammoniumbromide. Arch Int Pharmacodyn Ther. 1952 Sep 1;91(1-2):144–150. [PubMed] [Google Scholar]
  124. HAIBACH A. Gibt es eine Ticardasucht? Dtsch Med J. 1955 Feb 15;6(3-4):117–119. [PubMed] [Google Scholar]
  125. HAMMERL H., PICHLER O. [Spirographic studies with an antitussive agent (Salvigon)]. Wien Klin Wochenschr. 1962 Oct 26;74:739–741. [PubMed] [Google Scholar]
  126. HANKE F. Klinische Untersuchungen mit einem neuen Hustenmittel mit vorwiegend peripherem Angriffspunkt. Praxis. 1958 Jun 19;47(25):610–614. [PubMed] [Google Scholar]
  127. HANSEN K., ZIPF H. F. [Relation between bronchial tone and pulmonary vagus afferent nerves]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1960;238:78–79. [PubMed] [Google Scholar]
  128. HANSEN K., ZIPF H. [Relations between bronchotonus and lungvagus afferentia and their pharmacological modification]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1960;240:253–274. [PubMed] [Google Scholar]
  129. HARA S., YANAURA S. A method of inducing and recording cough and examination of the action of some drugs with this method. Jpn J Pharmacol. 1959 Sep;9:46–54. doi: 10.1254/jjp.9.46. [DOI] [PubMed] [Google Scholar]
  130. HASLREITER E. [The acetycholine cough test as a means of evaluation of a new antitussive agent]. Arzneimittelforschung. 1959 Dec;9:769–773. [PubMed] [Google Scholar]
  131. HEFFRON C. E. Preliminary evaluation of pholcodine, a new antitussive agent. J New Drugs. 1961 Sep-Oct;1:217–222. doi: 10.1177/009127006100100505. [DOI] [PubMed] [Google Scholar]
  132. HEIMENDINGER J. Die Therapie des Reizhustens mit einem neuen Mittel; Ticarda. Praxis. 1952 Apr 10;41(15):323–324. [PubMed] [Google Scholar]
  133. HENGEN O., KASPAREK H. Husten-hemmende Wirkung einer neuen Substanz. Arzneimittelforschung. 1958 Sep;8(9):620–620. [PubMed] [Google Scholar]
  134. HENRIQUET F., ROCHIRA G. [The use of Kat 256 (Silomat) in preanesthesia]. Minerva Anestesiol. 1963 Jan;29:25–28. [PubMed] [Google Scholar]
  135. HERZOG H. Polyäthylenglykolderivate mit hustenstillender Wirkung, insbesondere Tessalon. Schweiz Med Wochenschr. 1956 Jan 28;86(4):96–99. [PubMed] [Google Scholar]
  136. HILLS B. R., KELLY J. C. C. Effect of hexamethonium iodide on lobeline-stimulated coughing. Glasgow Med J. 1951 Mar;32(3):72–76. [PMC free article] [PubMed] [Google Scholar]
  137. HOGLUND N. J., MICHAELSSON M. A method for determining the cough threshold with some preliminary experiments on the effect of codeine. Acta Physiol Scand. 1950 Nov;21(2-3):168–173. doi: 10.1111/j.1748-1716.1950.tb00724.x. [DOI] [PubMed] [Google Scholar]
  138. HOTTINGER A. Klinische Erfahrungen mit Romilar einem neuen, synthetischen Hustenmittel. Schweiz Med Wochenschr. 1954 Dec 4;84(49):1372–1374. [PubMed] [Google Scholar]
  139. HUPERZ R. Erfahrungen mit einem neuartigen Hustenmittel in der Kinderpraxis. Medizinische. 1958 Jul 12;3(27-28):1105–1106. [PubMed] [Google Scholar]
  140. HUSEN J. H. Erfahrungen mit dem Hustenmedikament Tessalon. Tuberkulosearzt. 1958 Apr;12(4):248–253. [PubMed] [Google Scholar]
  141. Hahn K. J., Friebel H. Wirkungen hustenhemmender Pharmaka im zentralen Anteil der Hustenreflexbahn. Med Pharmacol Exp Int J Exp Med. 1966;14(1):87–97. [PubMed] [Google Scholar]
  142. ISBELL H., FRASER H. F. Actions and addiction liabilities of dromoran derivatives in man. J Pharmacol Exp Ther. 1953 Apr;107(4):524–530. [PubMed] [Google Scholar]
  143. IULIANI G., PAGNOTTA G. Esperienze cliniche con un nuovo bechico ad azione anestetica sul riflesso della tosse. G Clin Med. 1957 Apr;38(4):589–595. [PubMed] [Google Scholar]
  144. JACOBSSON B., KEWENTER J., KOCK N. G. Action of codeine and some other antitussive drugs on choledochal pressure and duodenal activity. A study in cholecystectomized patients. Acta Chir Scand. 1961 Nov;122:407–413. [PubMed] [Google Scholar]
  145. JAMAR J. Clinical data on carbetapentane. Int Rec Med Gen Pract Clin. 1955 Nov;168(11):735–736. [PubMed] [Google Scholar]
  146. KALLQVIST I., MELANDER B. Experimental and clinical evaluation of chlorcyclizine as an antitussive. Arzneimittelforschung. 1957 May;7(5):301–304. [PubMed] [Google Scholar]
  147. KASE Y. Pharmacological studies on cough reflex. 2. Cough depressing actions of various drugs. Jpn J Pharmacol. 1955 Mar;4(2):118–129. [PubMed] [Google Scholar]
  148. KASE Y. Pharmacological studies on cough reflex. 3. Coughing dog and its application. Jpn J Pharmacol. 1955 Mar;4(2):130–135. [PubMed] [Google Scholar]
  149. KASE Y., YUIZONO T., MUTO M. PIPERIDINO GROUPS IN ANTITUSSIVE ACTIVITY. J Med Chem. 1963 Mar;6:118–122. doi: 10.1021/jm00338a007. [DOI] [PubMed] [Google Scholar]
  150. KAUCHTSCHISCHWILI G. M. Esperienze cliniche su persone anziane con un nuovo antitosse. Gazz Med Ital. 1957 Mar;116(3):149–153. [PubMed] [Google Scholar]
  151. KEECH H. G., Jr ETHYL DIBUNATE: NEW NON-NARCOTIC FOR ACUTE COUGH. Pa Med J. 1963 Nov;66:39–40. [PubMed] [Google Scholar]
  152. KELENTEY B., CZOLLNER F., STENSZKY E., MESZAROS Z., SZLAVIK L. Darstellung und pharmakologische Untersuchung einiger morpholylaethylisierter Morphin-Derivate. Arzneimittelforschung. 1958 Jun;8(6):325–330. [PubMed] [Google Scholar]
  153. KELENTEY B., STENSZKY E., CZOLLNER F. Neue Untersuchungen zur Pharmakologie des Narceins. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1958;233(6):550–555. [PubMed] [Google Scholar]
  154. KELENTEY B., STENSZKY E., CZOLLNER F., SZLAVIK L., MESZAROS Z. Darstellung und pharmakologische Untersuchungen der N-Oxyde der Opium-Alkaloide. Arzneimittelforschung. 1957 Oct;7(10):594–597. [PubMed] [Google Scholar]
  155. KELLY D. F. A COMPARATIVE CLINICAL TEST OF PHOLCODINE WITH CODEINE AS CONTROL. Northwest Med. 1963 Nov;62:871–874. [PubMed] [Google Scholar]
  156. KLEIBEL F. EINE NEUE METHODIK DER ELEKTRO-AKUSTISCHEN REGISTRIERUNG VON HUSTENSTOESSEN UND IHRE ANWENDUNG BEI DER OBJEKTIVIERUNG DER WIRKUNG EINIGER ANTITUSSIVA. Med Welt. 1964 Jun 13;24:1317–1320. [PubMed] [Google Scholar]
  157. KLEIN B. EL JARABE PARA LA TOS COMO TERAP'EUTICA PALIATIVA. VALORACI'ON CL'INICA DEL PRODUCTO COTHERA. Folia Clin Int (Barc) 1963 Dec;13:608–611. [PubMed] [Google Scholar]
  158. KLEIN B. The cough sirup as palliative therapy; a clinical evaluation of dimethoxanate. Antibiotic Med Clin Ther (New York) 1958 Jul;5(7):462–465. [PubMed] [Google Scholar]
  159. KOHLI R. P., GUPTA G. P., BHARGAVA K. P. Effect of some newer compounds on experimental cough. Indian J Med Res. 1960 Mar;48:193–197. [PubMed] [Google Scholar]
  160. KONAR N. R., HALDER A. A CHEMICAL METHOD FOR EXCITING COUGH REFLEX AND TRIAL OF DIETHYLAMINOETHOXYETHYL ESTER OF ALPHA ALPHA-DIETHYLPHENYLACETIC ACID. J Indian Med Assoc. 1964 Jul 16;43:66–71. [PubMed] [Google Scholar]
  161. KONZETT H. Neuere Gesichtspunkte zur Pharmakologie des Narkotins. Wien Klin Wochenschr. 1955 May 6;67(18):306–309. [PubMed] [Google Scholar]
  162. KONZETT H., ROTHLIN E. Zur Wirkung von Narkotin auf den Hustenreflex und auf die Bronchialmuskulatur. Experientia. 1954 Nov 15;10(11):472–473. doi: 10.1007/BF02170409. [DOI] [PubMed] [Google Scholar]
  163. KRAUSE D. Pharmakologie des alpha(Isopropyl)-alpha-(beta-dimethylaminopropyl)-phenylacetonitril-citrat. Arzneimittelforschung. 1958 Aug;8(8):553–554. [PubMed] [Google Scholar]
  164. KRAUSHAAR A. E., SCHUNK R. W., THYM H. F. EIN NEUES ANTITUSSIVUM: 2-(BETA-HEXAMETHYLENIMINOATHYL)-CYCLOHEXANON-2-CARBONSAUREBENZYLESTER-HCL. Arzneimittelforschung. 1964 Sep;14:986–995. [PubMed] [Google Scholar]
  165. KUMMER A. Praktische Erfahrungen mit einem neuen Hustenmittel Romilar Roche. Praxis. 1955 Feb 10;44(6):132–132. [PubMed] [Google Scholar]
  166. LA BARRE J., PLISNIER H. A propos des propriétés antitussigènes et bronchodilatatrices du chlorhydrate de narcotine. Arch Int Pharmacodyn Ther. 1959 Mar 1;119(1-2):205–213. [PubMed] [Google Scholar]
  167. LACHNER O., WERNER H. [Observations and experiences in the use of the antitussive drug Silomat]. Wien Med Wochenschr. 1963 Mar 2;113:195–197. [PubMed] [Google Scholar]
  168. LANGER M. [On the use of oxolamine in bronchospastic syndromes. Clinical observations]. Minerva Med. 1961 Oct 31;52:3747–3750. [PubMed] [Google Scholar]
  169. LANGREHR D. [On the problem of receptor specificity of endoanesthetic effects based on the example of benzononatin (Tessalon)]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1963;245:427–439. [PubMed] [Google Scholar]
  170. LASAGNA L., BEECHER H. K. The analgesic effectiveness of nalorphine and nalorphine-morphine combinations in man. J Pharmacol Exp Ther. 1954 Nov;112(3):356–363. [PubMed] [Google Scholar]
  171. LEVIS S., PREAT S., MOYERSOONS F. [Not Available]. Arch Int Pharmacodyn Ther. 1955 Oct 1;103(2-3):200–211. [PubMed] [Google Scholar]
  172. LIBAL H. [Evaluation of a new antitussive agent by use of the comparative double blind test]. Med Welt. 1960 Feb 13;7:383–385. [PubMed] [Google Scholar]
  173. LIBAL H. [Evaluation of a new antitussive agent by use of the comparative double blind test]. Med Welt. 1960 Feb 13;7:383–385. [PubMed] [Google Scholar]
  174. LIECHTI J. Taoryl, ein neues hustenstillendes Mittel. Schweiz Med Wochenschr. 1950 May 6;80(18):484–485. [PubMed] [Google Scholar]
  175. LINDNER E., STEIN L. Abkömmlinge des Diphenyl-piperidino-propans; eine neue Reihe hustenstillender Mittel. Arzneimittelforschung. 1959 Feb;9(2):94–99. [PubMed] [Google Scholar]
  176. LINEBACK M. Benzonatate as cough and gag reflex suppressive. Clin Med (Northfield) 1962 Aug;69:1806–1808. [PubMed] [Google Scholar]
  177. LORENZI L. [Clinico-therapeutic observations on the use of oxolamine citrate in some forms of disease in childhood]. Gazz Med Ital. 1962 May;121:128–131. [PubMed] [Google Scholar]
  178. LUPACCHINI A., PAGANI E., VERGANI F. Contributo clinico allo studio di un nuovo calmante della tosse. Gazz Med Ital. 1956 Jul;115(7):200–201. [PubMed] [Google Scholar]
  179. Ladewig D. Neuere Suchttrends bei Jugendlichen. Schweiz Med Wochenschr. 1969 May 24;99(21):781–783. [PubMed] [Google Scholar]
  180. MACCAFERRI A., TROCCOLI B. [Use in geriatrics of a new antitussive product]. Minerva Med. 1960 Dec 1;51:4069–4072. [PubMed] [Google Scholar]
  181. MACHELLA M., CAMPOLUNGO A. [Results of therapy with Perebron in acute and chronic diseases of the respiratory tract]. Gazz Med Ital. 1962 Jun;121:158–159. [PubMed] [Google Scholar]
  182. MAFFII G., SILVESTRINI B., BANFI S. ANTITUSSIVE ACTIVITY OF A NEW LOCAL ANESTHETIC COMPOUND: BENZOBUTAMINE. Nature. 1963 Aug 31;199:916–917. doi: 10.1038/199916a0. [DOI] [PubMed] [Google Scholar]
  183. MARX H. H. Untersuchung der Atemdynamik nach Anaesthesierung der Dehnungsrezeptoren der Lunge. Arzneimittelforschung. 1957 Nov;7(11):663–664. [PubMed] [Google Scholar]
  184. MASI A. Primi risultati clinici sull'impiego di un derivato poliglicolico ad azione bechica. Riv Clin Pediatr. 1957 Jan;59(1):87–93. [PubMed] [Google Scholar]
  185. MAURER H. Die hustenstillende Wirkung von Verbindungen der Dromoran-Reihe. Dtsch Med Wochenschr. 1955 Mar 11;80(10):351–353. doi: 10.1055/s-0028-1116419. [DOI] [PubMed] [Google Scholar]
  186. MAY A. J., WIDDICOMBE J. G. Depression of the cough reflex by pentobarbitone and some opium derivatives. Br J Pharmacol Chemother. 1954 Sep;9(3):335–340. doi: 10.1111/j.1476-5381.1954.tb01689.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  187. MEGEMONT C., MEGEMONT I., BASTIDE P., DASTUGUE G. [Sensitizing action of some phenanthrene compounds, isoquinoline compounds or derivatives against acetylcholine in the presence of the isolated ventricle of Helix pomatia]. C R Seances Soc Biol Fil. 1961;155:1505–1507. [PubMed] [Google Scholar]
  188. MELIS A. [The therapeutic action of oxolamine in chronic bronchitis]. Minerva Med. 1961 Oct 31;52:3756–3758. [PubMed] [Google Scholar]
  189. MONTI G. B. IL PROBLEMA DELLA TOSSE NEL DECORSO POSTOPERATORIO. CONTRIBUTO TERAPEUTICO. Clin Ter. 1963 Sep 15;26:448–453. [PubMed] [Google Scholar]
  190. MORAWETZ H. Die Behandlung des Rheizhustens mit Ticarda. Med Welt. 1951 Nov 10;20(45):1416–1417. [PubMed] [Google Scholar]
  191. MULARGIA A. L'OXOLAMINA SOLA ED ASSOCIATA A TETRACICLINA NEL TRATTAMENTO DELLE AFFEZIONI CRONICHE DELLE VIE RESPIRATORIE. Policlinico Med. 1964 Jun;71:204–216. [PubMed] [Google Scholar]
  192. MULINOS M. G. Antitussive properties of morpholinethyl-morphine (pholcodine). Toxicol Appl Pharmacol. 1960 Nov;2:635–640. doi: 10.1016/0041-008x(60)90081-8. [DOI] [PubMed] [Google Scholar]
  193. MULINOS M. G., NAIR K. G., EPSTEIN I. G. Clinical investigation of antitussive properties of pholcodine. N Y State J Med. 1962 Jul 15;62:2373–2377. [PubMed] [Google Scholar]
  194. MURPHY V. S., HEATH M. M., SANSOCIE C. C. Clinical evaluation of a new nonnarcotic antitussive tablet in college students. J Am Coll Health Assoc. 1962 Dec;11:153–158. [PubMed] [Google Scholar]
  195. MUYSERS K., SIEHOFF F. [Respiratory physiological studies before and after the administration of alpha-(isopropyl)-beta-(2-dimethylaminopropyl)-phenylacetonitrile]. Arzneimittelforschung. 1960 Aug;10:663–664. [PubMed] [Google Scholar]
  196. NAEGELI H. R. Klinische Untersuchungen mit einem neuen Hustenbekämpfungsmittel. Praxis. 1956 Jan 19;45(3):56–58. [PubMed] [Google Scholar]
  197. NAGORNY S. [Clinical experiences with the new perorally and parenterally administrable antitussive silomat]. Med Klin. 1960 Dec 9;55:2254–2255. [PubMed] [Google Scholar]
  198. NAIR K. G., HAAR H. O. A study of the therapeutic and clinical effects of a derivative of pipendyl methane. N Y State J Med. 1956 Jun 1;56(11):1773–1777. [PubMed] [Google Scholar]
  199. NATHAN L. A. Clinical evaluation of chlophedianol a new nonnarcotic antitussive. Appl Ther. 1962 Sep;4:830–831. [PubMed] [Google Scholar]
  200. NERRETER W. Zur Frage der Süchtigkeit bei Hustenmitteln. Medizinische. 1957 Mar 16;(11):389–390. [PubMed] [Google Scholar]
  201. NEUMANN P. Le traitement de la toux dans les sanatoriums pour tuberculose pulmonaire. Rev Med Suisse Romande. 1956 Jun;76(6):738–742. [PubMed] [Google Scholar]
  202. NIELSEN I. M., NEUHOLD K. The comparative pharmacology and toxicology of the trans-isomer of 2-chloro-9-(3'-dimethylaminopropylidene)-thiaxanthene, HCl (chlorprothixene, N 714 trans) and chlorpromazine. Acta Pharmacol Toxicol (Copenh) 1959;15:335–355. doi: 10.1111/j.1600-0773.1959.tb00303.x. [DOI] [PubMed] [Google Scholar]
  203. NISSARDI G. P., CHERCHI P., SANNARANDACCIO F., TORRAZZA P. L. SULL'AZIONE DEL TRATTAMENTO PROLUNGATO CON OXOLAMINA CITRATO NELLA SILICOSI POLMONARE. Clin Ter. 1963 Dec 31;27:693–720. [PubMed] [Google Scholar]
  204. OSWALD N. C. Cough mixtures. Br Med J. 1959 Jan 31;1(5117):292–293. doi: 10.1136/bmj.1.5117.292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  205. OZAWA H., FUKUDA H., OTSUKI I., CHIBA S. [Antitussive activity and acute toxicity of 2-(2-diethylamino-ethoxy)ethyl alpha,alpha-diethylphenylacetate (oxeladin)]. Yakugaku Zasshi. 1962 Sep;82:1314–1317. [PubMed] [Google Scholar]
  206. PALAZZO G., CORSI G. Elimination of oxolamine in rat and in human beings. Arzneimittelforschung. 1962 May;12:545–546. [PubMed] [Google Scholar]
  207. PARISH F. A. Clinical evaluation of the antitussive, dimethoxanate. Med Times. 1959 Nov;87:1488–1490. [PubMed] [Google Scholar]
  208. PASQUARIELLO G., NICOLIS F. B. [Controlled clinical experiments with new antitussive drugs. II. Antitussive activity of benzobutamine]. Clin Ter. 1962 Aug 15;23:226–236. [PubMed] [Google Scholar]
  209. PAUL K. [Clinical experiences with a chemical and pharmacological new type antitussive agent]. Wien Z Inn Med. 1962 Mar;43:129–132. [PubMed] [Google Scholar]
  210. PELLMONT B., BACHTOLD H. Pharmakologie des Romilar Roche, einer hustenhemmenden Substanz mit zentralem Angriffspunkt. Schweiz Med Wochenschr. 1954 Dec 4;84(49):1368–1372. [PubMed] [Google Scholar]
  211. PETERSEN M. T. [2 Years of experience with peracon in general practice]. Dtsch Med J. 1960 May 5;11:235–236. [PubMed] [Google Scholar]
  212. PETROW V., STEPHENSON O., WILD A. M. The diethylaminoethoxyethyl ester of diethylphenylacetic acid; a new antitussive agent. J Pharm Pharmacol. 1958 Jan;10(1):40–46. doi: 10.1111/j.2042-7158.1958.tb10271.x. [DOI] [PubMed] [Google Scholar]
  213. PHILLIPS K. D., GUILLAUME E. W. A new antitussive. Practitioner. 1961 Feb;186:238–241. [PubMed] [Google Scholar]
  214. PITARMA SABINO A. C. [Clinical tests with a new synthetic anti-tussive: R-522. (Preliminary results)]. J Med (Oporto) 1960 Dec 31;43:996–997. [PubMed] [Google Scholar]
  215. PLATT M. L., ROWELL S. S., WOOLAS K. D. Clinical experience with 'Selvigon', a new antitussive. Br J Clin Pract. 1960 Dec;14:991–993. [PubMed] [Google Scholar]
  216. PLISNIER H. A propos de l'action des dérivés du phénanthrène et des substances synthétiques antitussigènes sur le bronchospasme posthistaminique et postacétylcholinique. C R Seances Soc Biol Fil. 1955 May;149(9-10):1070–1072. [PubMed] [Google Scholar]
  217. PLISNIER H. A propos des propriétés antitussigènes d'un bromure d'ammonium quaternaire: bromure de 2-triméthylamino-1, 2-diphényldiéthyléther (TDBr). C R Seances Soc Biol Fil. 1958;152(8-9):1267–1268. [PubMed] [Google Scholar]
  218. PLISNIER H. Etude comparative de l'action antitussigène des différents dérivés opiacés et synthétiques par rapport à celle du phosphate de codéine. Therapie. 1954;9(6):737–751. [PubMed] [Google Scholar]
  219. PLISNIER H. [Apropos of the antitussive and xronchoconstrictive properties of tetrahydro-1,4-oxazinylmethyl-codeine (pholcodine)]. C R Seances Soc Biol Fil. 1960;154:451–452. [PubMed] [Google Scholar]
  221. POZZETTO H., TRAMIER J. Diphenylpiperidinopropanol, new therapeutic antitussive agent. Lyon Med. 1963 Apr 7;209:829–843. [PubMed] [Google Scholar]
  222. PROKOP H., JOST F. Ticardasucht. Wien Klin Wochenschr. 1958 Mar 7;70(10):172–175. [PubMed] [Google Scholar]
  223. PRUESSING G. [On experiences with a new type of antitussive medication in postoperative irritative cough]. Dtsch Med J. 1960 Feb 20;11:95–96. [PubMed] [Google Scholar]
  224. RALPH N. Evaluation of a new cough suppressant. Am J Med Sci. 1954 Mar;227(3):297–303. [PubMed] [Google Scholar]
  225. RANDALL L. O., KRUGER J., CONROY C., KAPPELL B., BENSON W. M. Peripheral effects of the optical antipodes of 3-hydroxy-n-methyl-morphinan and some of their derivatives. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1953;220(1-2):26–39. doi: 10.1007/BF00246091. [DOI] [PubMed] [Google Scholar]
  226. RANDALL L. O., SELITTO J. J. Anti-inflammatory effects of romilar CF. J Am Pharm Assoc Am Pharm Assoc. 1958 May;47(5):313–314. [PubMed] [Google Scholar]
  227. RASCH M. Dextrometadons hostlindrande effekt. Nord Med. 1957 Apr 25;57(17):629–631. [PubMed] [Google Scholar]
  228. REHERMANN R. L. Pediatric experience with a new nonnarcotic antitussive agent. Curr Ther Res Clin Exp. 1962 Sep;4:487–491. [PubMed] [Google Scholar]
  229. REICHERTZ P., ZIPF H. F., HANSEN K. Vergleichende Prüfung verschiedener Endoanaesthetica an den Lungendehnungsrezeptoren des Meerschweinchens. Arzneimittelforschung. 1957 Dec;7(12):739–742. [PubMed] [Google Scholar]
  230. REICHLE C., FRIEBEL H. Zur Hemmung des Hustenreflexes durch zentral angreifende Arzneimittel. II. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1955;226(6):558–562. [PubMed] [Google Scholar]
  231. REPACI M. [The use of oxolamine citrate in the treatment of senile bronchopathies]. Minerva Med. 1960 Dec 1;51:4072–4077. [PubMed] [Google Scholar]
  232. RIEBEL A. F. [Results of clinical evaluation and research in respiration physiology with the new antitussive agent 1-(p-chlorophenyl)-2,3-dimethyl-4-dimethylamino-2-butanol HCl]. Arzneimittelforschung. 1960 Oct;10:794–796. [PubMed] [Google Scholar]
  233. RIESS O., TONJES H. Fortschrittliche Behandlung der Hustens mit Ticarda. Med Monatsschr. 1951 Jun;5(6):415–416. [PubMed] [Google Scholar]
  234. RIMOLDI R. [The use of alpha-isopropyl-alpha-(beta-dimethylaminopropyl)-phenylacetonitrile citrate as an antitussive drug]. G Ital Tuberc Mal Torace. 1960 Jul-Aug;14:243–245. [PubMed] [Google Scholar]
  235. ROHR J. H. A new noscapine formulation for the relief of symptoms associated with respiratory tract disorders. Curr Ther Res Clin Exp. 1962 Jan;4:21–23. [PubMed] [Google Scholar]
  236. ROSIERE C. E., WINDER C. V., WAX J. Ammonia cough elicited through a tracheal side tube in unanesthetized dogs: comparative antitussive bioassay of four morphine derivatives and methadone in terms of ammonia thresholds. J Pharmacol Exp Ther. 1956 Mar;116(3):296–316. [PubMed] [Google Scholar]
  237. ROTTINI E., MARRI G., CALANDRA P. [The recent introduction in therapy of a new antitussive drug: oxolamine]. Minerva Med. 1961 Oct 31;52:3758–3760. [PubMed] [Google Scholar]
  238. Rece C. A., Cherry A. C., Jr, Reece A. T., Hatcher T. B., Diehl A. M. Tape recorder for evaluation of coughs in children. Am J Dis Child. 1966 Aug;112(2):124–128. doi: 10.1001/archpedi.1966.02090110068005. [DOI] [PubMed] [Google Scholar]
  239. Renovanz H. D., Liebrich K. G. Prüfung von Hustenmitteln, dargestellt am Beispiel von 1-p-Chlorphenyl-2,3-dimethyl-4-dimethylamino-butanol-(2).HCl. Arzneimittelforschung. 1965 Dec;15(12):1393–1411. [PubMed] [Google Scholar]
  240. SALEM H., AVIADO D. M. ANTITUSSIVE DRUGS, WITH SPECIAL REFERENCE TO A NEW THEORY FOR THE INITATION OF THE COUGH REFLEX AND THE INFLUENCE OR BRONCHODILATORS. Am J Med Sci. 1964 May;247:585–600. [PubMed] [Google Scholar]
  241. SAUNDERS D. C. Trial of an anti-tussive preparation in droplet form. Practitioner. 1961 Mar;186:367–369. [PubMed] [Google Scholar]
  242. SCHAARE U. Erfahrungen mit Spasmo-Cibalgin compositum. Medizinische. 1958 Nov 8;32(45):1838–1838. [PubMed] [Google Scholar]
  243. SCHALLEK W., WALZ D. Cardiovascular and central nervous system effects of morphinan series. Proc Soc Exp Biol Med. 1954 Oct;87(1):233–236. doi: 10.3181/00379727-87-21344. [DOI] [PubMed] [Google Scholar]
  244. SCHMID J. Ticarda als Suchtmittel. Dtsch Med Wochenschr. 1954 Jul 30;79(31-32):1191–1191. [PubMed] [Google Scholar]
  245. SCHMIDT F. [Clinical experiences with a new antitussive agent with special consideration of the physiological and pathophysiological process during the act of coughing]. Praxis. 1960 Oct 20;49:1001–1003. [PubMed] [Google Scholar]
  246. SCHMIDT W. [Clinical experiences with a new antitussive and expectoration-promoting preparation]. Med Welt. 1960 Feb 27;9:505–506. [PubMed] [Google Scholar]
  247. SCHMIEDEL R. Klinischer Vergleich einer neuen hustenstillenden Substanz (Peracon) mit Codein und Dicodid. Ther Ggw. 1959 May;98(5):239–240. [PubMed] [Google Scholar]
  248. SCHOETENSACK W., HALLMANN G. DIE VERATRAMIN-ERREGUNG UND IHRE PHARMAKOLOGISCHE BEEINFLUSSUNG. Arzneimittelforschung. 1964 May;14:428–432. [PubMed] [Google Scholar]
  249. SCHOFIELD P. B. TRIAL OF DIMYRIL IN GENERAL PRACTICE. Br J Clin Pract. 1963 Oct;17:583–586. [PubMed] [Google Scholar]
  250. SCHROEDER W. Die Verwendung des Vagusschlingenhundes für die Wertbestimmung hustenstillender Substanzen. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1951;212(5-6):433–439. [PubMed] [Google Scholar]
  251. SCHUMACHER G. [Contribution to the treatment of cough]. Ther Ggw. 1959 Dec;98:581–582. [PubMed] [Google Scholar]
  252. SEGAL M. S. Current status of therapy in bronchial asthma. J Am Med Assoc. 1959 Mar 7;169(10):1063–1071. doi: 10.1001/jama.1959.73000270005011. [DOI] [PubMed] [Google Scholar]
  253. SEGAL M. S., DULFANO M. J. Therapy of chronic pulmonary emphysema. GP. 1953 Jan;7(1):57–62. [PubMed] [Google Scholar]
  254. SEGAL M. S., GOLDSTEIN M. M., ATTINGER E. O. The use of noscapine (narcotine) as an antitussive agent. Dis Chest. 1957 Sep;32(3):305–309. doi: 10.1378/chest.32.3.305. [DOI] [PubMed] [Google Scholar]
  255. SELL R., LINDNER E., JAHN H. Untersuchungen über die Anaesthesie der Dehnungs- und Berührungsreceptoren durch einige Lokalanaesthetica im Vergleich zur hustenstillenden Wirkung. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1958;234(2):164–178. [PubMed] [Google Scholar]
  256. SEVELIUS H., LESTER P. D., COLMORE J. P. OBJECTIVE EVALUATION OF ANTITUSSIVE AGENTS. Clin Pharmacol Ther. 1965 Mar-Apr;6:146–151. doi: 10.1002/cpt196562146. [DOI] [PubMed] [Google Scholar]
  257. SHANE S. J., KRZYSKI T. K., COPP S. E. Clinical evaluation of a new antitussive agent. Can Med Assoc J. 1957 Sep 15;77(6):600–602. [PMC free article] [PubMed] [Google Scholar]
  258. SILVESTRINI B., POZZATTI C. PHARMACOLOGICAL PROPERTIES OF 3-ALPHA-PHENYLPROPYL-5-BETA-DIETHYLAMINOETHYL-1,2,4-OXADIAZOLE CITRATE. Arzneimittelforschung. 1963 Sep;13:798–802. [PubMed] [Google Scholar]
  259. SIMON S. W. A comparative study of two new non-narcotic antitussive drugs. Ohio State Med J. 1957 Dec;53(12):1426–1427. [PubMed] [Google Scholar]
  260. SIMON S. W. A new non-narcotic, antitussive drug. Ann Allergy. 1957 Sep-Oct;15(5):521–525. [PubMed] [Google Scholar]
  261. SIMON S. W. A new tablet for the cough of chronic lung disease. Ohio State Med J. 1963 Jul;59:687–688. [PubMed] [Google Scholar]
  262. SIMON S. W. The effectiveness of non-narcotic antitussive drugs. J Am Geriatr Soc. 1962 Aug;10:653–657. doi: 10.1111/j.1532-5415.1962.tb00162.x. [DOI] [PubMed] [Google Scholar]
  263. SIRONI P. G. Sull'impiego in anestesia del fenilciclopentano-carbossilato di dietilamino-etossietile quale farmaco antitussigeno. Minerva Anestesiol. 1956 Dec;22(12):413–415. [PubMed] [Google Scholar]
  264. SKURSKY J. Ein neuartiges, hustenstillendes, Medikament (Romilar Roche). Wien Med Wochenschr. 1959 Jun 13;109(24):507–508. [PubMed] [Google Scholar]
  265. SNELL E. S., ARMITAGE P. Clinical comparison of diamorphine and pholcodine as cough suppressants by a new method of sequential analysis. Lancet. 1957 Apr 27;272(6974):860–862. doi: 10.1016/s0140-6736(57)91392-2. [DOI] [PubMed] [Google Scholar]
  266. SNYDER G. G. An evaluation of caramiphen ethane disulfonate as an antitussive agent. Laryngoscope. 1953 Oct;63(10):1008–1013. doi: 10.1288/00005537-195310000-00009. [DOI] [PubMed] [Google Scholar]
  267. SOZIO N., MARTELLOTTA G., PELLEGRINOV, ABBAMONTE P. [Effect of oxolamine on respiratory function, carbonic anhydrase and prothrombin level in pulmonary tuberculosis]. Minerva Med. 1961 Oct 31;52:3760–3763. [PubMed] [Google Scholar]
  268. SPORN O. Taoryl in der Kinderheilkunde. Praxis. 1952 Jul 10;41(28):615–615. [PubMed] [Google Scholar]
  269. SVOBODA H. Therapeutische Notiz über Taoryl, ein neues Hustenmittel mit broncholytischer Wirkung. Praxis. 1950 Dec 21;39(51):1108–1110. [PubMed] [Google Scholar]
  270. Sevelius H., Colmore J. P. Antitussive effect of ethyl dibunate in patients with chronic cough. Clin Pharmacol Ther. 1967 May-Jun;8(3):381–384. doi: 10.1002/cpt196783381. [DOI] [PubMed] [Google Scholar]
  271. Silvestrini B., Pozzatti C. Pharmacological properties of 3-phenyl-5beta diethylaminoethyl-1,2,4-oxadiazole. Br J Pharmacol Chemother. 1961 Jun;16(3):209–217. doi: 10.1111/j.1476-5381.1961.tb01080.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  272. TACCANI G. [On the therapeutic value of an antitussive agent]. Minerva Med. 1959 Dec 26;50:4396–4398. [PubMed] [Google Scholar]
  273. TESTAFERRATA A., FRANCALANCIA L. [Clinical experience on the possibility of use of oxolamine citrate in pediatrics]. Minerva Med. 1960 Dec 1;51:4064–4069. [PubMed] [Google Scholar]
  274. THALBERG R. E. Clinical trial of a new antitussive agent. West Med Med J West. 1962 Dec;3:473–474. [PubMed] [Google Scholar]
  275. TONER J. J., MACKO E. Pharmacology studies on bis-(1-carbo-beta-diethylaminoethoxy)-1-phenylcyclopentane)-ethane disulfonate. J Pharmacol Exp Ther. 1952 Oct;106(2):246–251. [PubMed] [Google Scholar]
  276. TRENDELENBURG U. Uber die Wirkung einiger Hustenmittel auf Hustenreiz-schwelle und Atmung. Acta Physiol Scand. 1950 Nov;21(2-3):174–186. doi: 10.1111/j.1748-1716.1950.tb00725.x. [DOI] [PubMed] [Google Scholar]
  277. TROPIA G. [On the use of oxolamine citrate in bronchitic recurrences]. Minerva Med. 1961 Oct 31;52:3750–3752. [PubMed] [Google Scholar]
  278. TUNNERHOFF F. K., SCHWABE H. K. Untersuchungen zur Frage der Verwendbarkeit Synthetischer Methoxy-Methyl-Morphinane; Beitrag zur Therapie der verschiedenen Hustenformen bei Lungentuberkulose. Klin Wochenschr. 1955 Jun 15;33(23-24):576–580. doi: 10.1007/BF01473770. [DOI] [PubMed] [Google Scholar]
  279. ULDALL P. R., WALTON J. N., NEWELL D. J. Chlorphenoxamine hydrochloride in parkinsonism. A controlled trial. Br Med J. 1961 Jun 10;1(5240):1649–1652. doi: 10.1136/bmj.1.5240.1649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  280. UMEHARA S., UEKI M., ITO H., ISHII A., TABAYASHI T., KOSHIISHI Y., MUKAI T. [Clinical experience with oxolamine (Perebron)]. Minerva Med. 1961 Oct 31;52:3741–3745. [PubMed] [Google Scholar]
  281. VALENTI S., DE PALMA M. Terapia della tosse irritativa con un anestetico dei recettori dell'espansione polmonare. Gazz Med Ital. 1958 May;117(5):194–196. [PubMed] [Google Scholar]
  282. VAN DONGEN K. The effect of narcotine, ticarda and romilar on coughs and on the movements of the cilia in the air passages. Acta Physiol Pharmacol Neerl. 1956 Mar;4(4):500–507. [PubMed] [Google Scholar]
  283. VASSELIN M. [Cough sedatives]. Fr Med. 1960 Mar;23:151–157. [PubMed] [Google Scholar]
  284. VERSIE R., NOIRFALISE A., NEVEN M., MALCHAIR R. [The toxicity and metabolism of 3 methoxy-N-methyl morphinane (Romilar) in the child]. Ann Med Leg Criminol Police Sci Toxicol. 1962 Nov-Dec;42:561–565. [PubMed] [Google Scholar]
  285. VILLAR T. [Our experience with a new antitussive agent, Silomat, in bronchoscopy and bronchography]. J Med (Oporto) 1962 Dec 15;49:1006–1008. [PubMed] [Google Scholar]
  286. VIRCHOW C. [Clinical tests of a new antitussive substance]. Praxis. 1961 Jun 22;50:660–661. [PubMed] [Google Scholar]
  287. WAX J., WINDER C. V., PETERS G. An antitussive property of diphenhydramine in dogs. Proc Soc Exp Biol Med. 1962 Jul;110:600–603. doi: 10.3181/00379727-110-27591. [DOI] [PubMed] [Google Scholar]
  288. WIEDEMEIJER J. C., KRAMER H. W., de JONGH D. A screening method for antitussive compounds. Acta Physiol Pharmacol Neerl. 1960;9:501–508. [PubMed] [Google Scholar]
  289. WILLNER K. [Excretion and decomposition of 3-methoxy-N-methylmorphinan and its demethylated derivatives in man]. Arzneimittelforschung. 1963 Jan;13:26–29. [PubMed] [Google Scholar]
  290. WINDER C. V., WAX J., SERRANO B., SCOTTI L., STACKHOUSE S. P., WHEELOCK R. H. Pharmacological studies of 1,2-dimethyl-3-phenyl-3-propionoxypyrrolidine (CI-427), an analgetic agent. J Pharmacol Exp Ther. 1961 Jul;133:117–128. [PubMed] [Google Scholar]
  291. WINTER C. A., FLATAKER L. Antitussive compounds: testing methods and results. J Pharmacol Exp Ther. 1954 Sep;112(1):99–108. [PubMed] [Google Scholar]
  292. WINTER C. A., FLATAKER L. The effects of drugs upon a graded cough response obtained in sensitized guinea pigs exposed to aerosol of specific antigen. J Exp Med. 1955 Jan 1;101(1):17–24. doi: 10.1084/jem.101.1.17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  293. WINTER C. A., FLATAKER L. Toxicity studies on noscapine. Toxicol Appl Pharmacol. 1961 Jan;3:96–106. doi: 10.1016/0041-008x(61)90013-8. [DOI] [PubMed] [Google Scholar]
  294. Willcox W. H. Norman Kerr Memorial Lecture ON DRUG ADDICTION: Delivered before the Society for the Study or Inebriety, October 9th, 1923. Br Med J. 1923 Dec 1;2(3283):1013–1018. doi: 10.1136/bmj.2.3283.1013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  295. ZIEHME E. [Lorfan, a new morphine antagonist in poisonings in children]. Kinderarztl Prax. 1960 Mar;28:101–104. [PubMed] [Google Scholar]
  296. ZUR LINDEN Hustenreizstillung ohne Suchtgefahr. Medizinische. 1958 Jun 7;3(23):959–960. [PubMed] [Google Scholar]
  297. de ALEMQUER, LEAL F., GOMES F. P. [Therapeutic trial of the resinat of noscapine as an antitussive agent]. J Med (Oporto) 1960 Dec 3;43:681–687. [PubMed] [Google Scholar]
  298. de ALEMQUER, LEAL F. [Therapeutic trial of trimethyl-(1,2-diphenylethoxyethyl)-ammonium bromide (TDBr) as an antitussive agent]. J Med (Oporto) 1962 Dec 1;49:839–840. [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES